Eserine Salicylate
水杨酸毒扁豆碱
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameEserine Salicylate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesYale University
Inactive CompaniesMedical University Of GrazAstrazeneca PlcGoethe University
Active Indications
Inactive Indications